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                                                       ABSTRACT 
 
This work presents a method for the direct, centrifugally induced fabrication of small, Ca
2+
 
cross-linked alginate beads at syringe needle micro-nozzles. The bead diameter was found 
between 65-282.5 µm and rpm between 1900-200 rpm. Centrifuge tube-syringe set up is 
aligned vertically at rest in flying bucket and under rotation they align horizontally. The 
centrifugally induced, ultra-high artificial gravity conditions allow the micro-encapsulation of 
alginate solutions. With this low cost technology for fabrication of micro alginate beads, 
beads with less than 300 µm have been formed. 
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1.1  INTRODUCTION 
 
Microencapsulation is a process in which small particles are surrounded by a coating to give 
protection. Three major areas where microencapsulation is in use are-food production, 
cosmetic industry, drug delivery [1]. 
In the area of food production, enzymes and vitamins are encapsulated to increase the effect 
of nutrition. Similarly for cosmetic industry, colours and flavours are encapsulated [2]. 
Conventional techniques like spray drying is used for these encapsulation as diameter of 
these encapsulated beads requires 100-1000 µm [3]. Drug delivery is another field where two 
things are focussed. One is encapsulation and other is release of pharmaceuticals in controlled 
manner, e.g. for cancer therapy. The living cells are encapsulated to replace the failed body 
functions, e.g. in diabetes. This requires small size encapsulation for diffusive mass transport 
[4]. 
 
This project focuses on formation of micro-alginate beads and the encapsulation of living 
cells into biocompatible and biodegradable polymer like alginate which are being 
investigated for in-vivo application. Biopolymer like alginate has been extensively used here. 
Alginate is an anionic polysaccharide or biopolymer which is found in cell wall of brown 
algae. Sodium alginate solution hardens once it comes in contact with Ca
2 +
 ions [5]. The 
coatings of calcium alginate is semi-permeable in nature. The immune system do not 
recognize the encapsulated alien cells. The cells remain in healthy conditions due to available 
of nutrition thorough diffusive transport of nutrition and allowing metabolic process to 
continue. Thus it is used in implantation. For cell therapy, the optimum size 50-300 µm has 
been suggested. In 1908, the insulin producing pancreatic cells were encapsulated into 
alginate beads [6]. 
Production of micro-alginate beads require two challenges to be overcome. First the surface 
tension and viscous force which stops the droplet to break-off at the needle tip must 
overcome. Secondly, there should not be clogging or agglomeration. There are two major 
ways for cell encapsulation [7]. 
Direct method implies the passage of alginate solution through air gap into CaCl2 solution 
where they are instantaneously hardened [8]. The air gap prevents premature hardening and 
clogging at the nozzle. The vibration at the nozzle causes droplet to break-off. But these 
technique requires complex and costly apparatus. 
Indirect methods requires removal of oil from the surface of bead thus making throughput of 
these indirect method less than that of direct method [9]. 
This project uses the technique of centrifugally induced micro-encapsulation. This novel 
technique can form microbeads with highly viscous alginate solution without compromising 
on the vitality of cells. Here a centrifuge tube-syringe setup is made where alginate solution 
contained in syringe is diffusion based hardened by CaCl2 solution present in centrifuge tube. 
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2.1 LITERATURE REVIEW: 
 
 2.1.1.1 Sodium alginate  
 It is cationic polysaccharide found in cell wall of brown algae. It is biocompatible                      
and is used as biomaterial. The random sequence of Mannuronic acid(M) and Guluronic 
acid(G) comprises alginate. It’s empirical formula is NaC6H7O6. It is used in food industry, 
removing radioactive substance from body since it is an effective chelator, immobilisation of 
cells to obtain alcohols [10]. 
2.1.1.2 Calcium alginate 
 
It is prepared by adding CaCl2 solution with aqueous sodium alginate. It’s chemical formula 
is C12H14CaO12. It is widely used in medicine industry. It includes burn dressings which helps 
to heal. It is widely used in immobilisation and encapsulation due to it’s biocompatibility and 
gelation property [11]. 
 
2.1.2. Crosslinking mechanism 
Alginate polymer can be shown as in fig. 1(a). 
 
(a)                                                                                  (b) 
                                        Fig. 1: Crosslinking mechanism 
 
Calcium ions is used for cross linking because of its non-toxicity. When calcium ions in the 
solution come in contact with sodium alginate, the calcium ions replace the sodium ions in 
the polymer [12]. Each calcium ions attach to two of the polymer strands. This is called cross 
linking and  in represented  in fig. 1(b). 
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2.1.3 Bead formation: 
Alginate forms gels with wide range of cations. Size of beads can be controlled by regulating 
various parameters. As we increase the concentration of calcium ions, the positive calcium 
ions take up places next to the negative ions and there lies less space for water molecules. 
This makes hydrogel beads loose some water. The negative charges along the chain repel 
each other less in the presence of sodium ions and so chains become more coiled up and this 
squeezes out water from bead [13]. 
2.1.4 Principle of operation: 
There are two basic droplet formation mechanism for a nozzle of inner diameter dn exposed 
to gravity which is depicted in fig. 2. 
 
 
(a) (b) 
                              Fig. 2: Droplet formation mechanism (adapted from [7]) 
As gravitational force Fg exceeds the surface tension induced counter force, there is droplet 
formation as depicted in fig. 2(a). A jet is issued out of nozzle at high flow rate. As depicted 
in fig. 2(b). By equating the two forces, we can calculate the theoretical bead diameter ddrop 
where dn in diameter of nozzle, σdrop is surface tension of drop, ρ in density of drop [14]. 
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But by using centrifugation, one can produce artificial gravity conditions and g can be 
expressed as ω2r  where ω is angular frequency and r is radial position of nozzle. 
2.1.5  Encapsulation  
Microencapsulation is a process in which small particles are surrounded by a coating to give 
protection. Three major areas where microencapsulation is in use are-food production, 
cosmetic industry, drug delivery [15]. 
2.1.5.1 Reasons for microencapsulation 
It is used to prolong the life of products that are encapsulated, control its liberation in 
appropriate time and space. The product need to be isolated from the surrounding, like in case 
of vitamins isolated to prevent it from harmful effects of oxygen, reducing evaporation of 
volatile core, separating reactive core from chemical attack [16]. The objective is not to 
isolate core from surrounding but to control the rate at which it leaves and reaches to its 
surrounding as in controlled release of drug or pesticides. Encapsulation of cells is of 
important concern here [17]. The immune system do not recognize the encapsulated alien 
cells. The cells remain in healthy conditions due to available of nutrition thorough diffusive 
transport of nutrition and allowing metabolic process to continue [18]. Thus it is used in 
implantation. Here the strength and elasticity of microcapsule must remain high for long time 
and smooth surfaces are required to prevent immunologic reactions [19]. 
2.1.5.2 Cell encapsulation: 
It involves immobilisation of cells within polymer that allows bidirectional diffusion of 
molecules such as growth factors, influx of oxygen, nutrients which are necessary for cell 
metabolism and diffusion of waste products and therapeutic proteins [20]. It also prevents 
cells from immune cells and antibodies. The idea behind cell encapsulation is to overcome 
the problem of graft rejection in tissue engineering. Though therapeutic products can be 
injected at the site of implantation , encapsulated cells would provide therapeutic products to 
the affected site in a controlled and for longer duration [21]. In drug delivery implantation of 
drug loaded artificial cell would be more cost effective that direct drug delivery and 
prolonged drug deliver [22]. 
It is necessary to ensure that the microcapsule has adequate mechanical stability to withstand  
physical and osmotic stress such as during the exchange of nutrients and waste products.  
[23]The microcapsules should be strong enough and should not rupture on implantation as 
this could lead to an immune rejection of the encapsulated cells. [24]For instance, in the case 
of xenotransplantation, a tighter more stable membrane would be required in comparison to  
allo-transplantation [25]. 
2.1.5.2.1 Non-Therapeutic applications 
Cell microencapsulation is used in food industry for the encapsulation of live probiotic 
bacteria cells. This is done to prolong bacteria viability during processing of diary products 
and targeted delivery to the gastrointestinal tract [26]. 
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2.1.5.2.2 Therapeutic Applications 
 
For diabetes microencapsulation technique can make use of animal cells or genetically 
modified insulin producing cells or protect the islets cells from immune response. These islets 
encapsulated microcapsules could prevent the need for insulin injections [27]. 
For  cancer, there can be cure by implantation of microcapsules containing genetically 
modified cytokine secreting cells [28]. The effect of implanting microcapsules loaded with 
xenogenic cells genetically modified to secrete endostatin, an antiangiogenic drug which 
causes apoptosisin tumor cells, has been extensively studied [29]. 
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3.1Objectives 
 
 Finding the minimum rpm at which micro-alginate beads formed. 
 Preparation of micro-beads between 50-300 µm which is good for implantation. 
 Studying the effect of micro-alginate bead diameter with rpm and concentration. 
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3.2 Work Plan 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
            
 
Preparation of 1%, 2%, 3% sodium alginate using distilled water 
 
Preparation of centrifuge tube-syringe setup for 26G, 30G needle 
                      Preparation of 100 mM CaCl2 solution + 0.1 w% Tween 80 
 
Centrifuging 1% alginate solution using 26G, 30 G needle and viewing it under 
microscope 
Centrifuging 2% alginate solution using 26G, 30 G needle and viewing under it 
microscope 
 
Centrifuging 3% alginate solution using 26G, 30 G needle and viewing it under 
microscope 
 
Calculating theoretical diameter of micro-alginate beads formed from 1%, 2%, 3% 
alginate solution using 26G, 30G syringe needle 
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4.1 Preparation of centrifuge tube-syringe setup  
4.1.1 For 26G needle 
Using driller machine, holes were made on centrifuge cap as shown in fig.3(a). Then holes 
were made on both sides of 2 ml syringe as shown in fig. 3(b). This was done for 10 number 
of 2ml syringe as shown in fig.3(c). Then centrifuge caps were holed and syringe was 
inserted into hole made in centrifuge cap as shown in fig. 3(d). 50 ml centrifuge tube were 
holed on both sides. This was done for 10 number of centrifuge tube. Then the centrifuge cap 
was inserted into centrifuge tube to make the complete setup as shown in fig. 3(e). 
 
                                                                         (a)                                                                                                                                           
 
                          (b)                    (c)                                (d)                              (e) 
Fig. 3: Centrifuge tube-syringe setup for 26G syringe made by making holes in (a) 
centrifuge cap (b) syringe (c) 10 centrifuge cap and syringe (d) centrifuge tube (e) 10 
centrifuge tube.  
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4.1.2 For 30G needle 
Using driller machine, holes were made on centrifuge cap as shown in fig.4(a). Then holes 
were made on both sides of 1 ml syringe as shown in fig. 4(b). This was done for 10 number 
of 1ml syringe. Then centrifuge caps were holed and syringe was inserted into hole made in 
centrifuge caps. 10 centrifuge caps were holed as shown in fig. 4(c). 50 ml centrifuge tube 
were holed on both sides as shown in fig. 4(d). This was done for 10 number of centrifuge 
tube. Then the centrifuge cap was inserted into centrifuge tube to make the complete setup as 
shown in fig. 4(e). 
 
(a) 
                                                                      
         (b)                   (c)                            (d)                              (e) 
Fig. 4: Centrifuge tube-syringe setup for 30G syringe made by making holes in (a) 
centrifuge cap (b) syringe (c) 10 centrifuge cap and syringe (d) centrifuge tube  (e) 10 
centrifuge tube. 
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4.2 Preparation of 1%, 2%, 3% alginate solution 
4.2.1 For preparing 1% alginate solution. 
99 ml of distilled water was taken in 500 ml beaker and kept on magnetic stirrer at 400 rpm 
and 1 g of alginate was poured in distilled water slowly and kept overnight for 16 hours. 
4.2.2 For preparing 2% alginate solution. 
98 ml of distilled water was taken in 500 ml beaker and kept on magnetic stirrer at 500 rpm 
and 2 g of alginate was poured in distilled water slowly and kept overnight for 16 hours.  
4.2.3 For preparing 3% alginate solution 
97 ml of distilled water was taken in 500 ml beaker and kept on magnetic stirrer at 600 rpm 
and 3 g of alginate was poured in distilled water slowly and kept overnight for 16 hours.  
4.3 Preparation of 100 mM CaCl2 solution with 0.1 w% Tween-80 
For preparing 100 ml of 100 mM CaCl2, 1.109 g of CaCl2 was dissolved in measuring 
cylinder containing distilled water till volume of solution becomes 100 ml. 100 µl of tween-
80 was dissolved in prepared solution. 
4.4 Experimental setup 
In this novel, rotor based set-up, droplets were generated within the dripping regime at the 
micro-nozzle tip of a commercially available syringe. The syringe contains alginate solution 
and centrifuge tube contains CaCl2 solution. Therefore, the alginate droplet impacts 
perpendicular to the air–liquid meniscus within the tube. Upon halting the rotor, gravity 
prevails to realign the tube in a vertical position. The Centrifuge tube-syringe setup can be 
taken out of the rotor for further processing, e.g. culturing or analysis. Due to the intrinsic 
rotational symmetry, several nozzles can be operated simultaneously on the same rotor. 
 
Fig.5: Schematic of the experimental setup consisting of centrifugal platform and 
centrifuge tube-syringe setup in a swinging bucket 
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4.5 Centrifugation and viewing it under microscope 
The centrifuge tube-syringe setup was put inside centrifuge machine and cap was put on and 
centrifuge lid was closed and temperature, time, rpm was set. The formed beads were viewed 
under microscope. 
 
 
(a)                                                                (b) 
 
 
   (c) 
Fig. 6: (a) Centrifuge tube-syringe set up was kept in centrifuge machine (b) the cap was 
put on (c) rpm, temperature, time was set and centrifuge was run. 
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4.5.1 Formation of beads for 1% alginate solution using 26G needle. 
Ten setup was marked as A, B, C, D, E, F, G, H, I, J. A and B were used as test to find 
minimum rpm at which beads formed. 5 ml of CaCl2 was put in each centrifuge tube and 1 ml 
of alginate solution in each syringe. 
4.5.2 Formation of beads for 1% alginate solution using 30G needle. 
Ten setup was marked as A, B, C, D, E, F, G, H, I, J.  A and B were used as test to find 
minimum rpm at which beads formed. 5 ml of CaCl2 was put in each centrifuge tube and 0.25 
ml of alginate solution in each syringe. 
4.5.3 Formation of beads for 2% alginate solution using 26G needle. 
Ten setup was marked as A, B, C, D, E, F, G, H, I, J. A and B were used as test to find 
minimum rpm at which beads formed. 5 ml of CaCl2 was put in each centrifuge tube and 1 ml 
of alginate solution in each syringe. 
4.5.4 Formation of beads for 2% alginate solution using 30G needle. 
Ten setup was marked as A, B, C, D, E, F, G, H, I, J. A and B were used as test to find 
minimum rpm at which beads formed. 5 ml of CaCl2 was put in each centrifuge tube and 0.25 
ml of alginate solution in each syringe. 
4.5.5 Formation of beads for 3% alginate solution using 26G needle. 
Ten setup was marked as A, B, C, D, E, F, G, H, I, J. A and B were used as test to find 
minimum rpm at which beads formed. 5 ml of CaCl2 was put in each centrifuge tube and 1 ml 
of alginate solution in each syringe. 
4.5.6 Formation of beads for 3% alginate solution using 30G needle. 
Ten setup was marked as A, B, C, D, E, F, G, H, I, J. A and B were used as test to find 
minimum rpm at which beads formed. 5 ml of CaCl2 was put in each centrifuge tube and 0.25 
ml of alginate solution in each syringe. 
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5.1 Micro-alginate beads from 1% alginate solution with 26G Syringe (O.D (450 µm), 
I.D (250 µm)): 
300 rpm was the least rpm at which beads formed. Diameter of beads was found to be 282.5 
µm as shown in fig. 7(a). The formation of beads was checked for three other rpm, say 400, 
500, 600 rpm and the diameter of microbeads was found as 227.5 µm as shown in fig. 7(b), 
185 µm as shown in fig. 7(c), 172.5 µm as shown in in fig. 7(d) respectively. From the graph 
it can be seen that as the rpm increased the bead diameter decreased.  
 
(a)                                                                         (b) 
 
 
                               (c)                                                                        (d) 
Fig. 7: Micro-alginate beads formed at (a) 400 rpm having diameter 282.5 µm (b) 500 
rpm having diameter 227.5 µm (c) 600 rpm having diameter 185 µm (d) 700 rpm having 
diameter 172.5 µm using 1% alginate and 26G syringe. 
 
5.2 Micro-alginate beads from 1% alginate solution with 30G syringe needle (O.D (300 
µm), I.D (148 µm)) 
There was no formation of beads at 400 rpm. 500 rpm was the least rpm at which beads 
formed. Diameter of beads was found to be 190µm as shown in fig. 8(a). The formation of 
beads was checked for three other rpm, say 600, 700, 800 rpm and the diameter of 
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microbeads was found as 162.5 µm, 157.5 µm, 132.5 µm. From the graph it can be seen that 
as the rpm increased the bead diameter decreased.  
 
(a)                                                                  (b) 
 
 
                                 (c)                                                                    (d) 
Fig.8: Micro-alginate beads formed at (a) 500 rpm having diameter 190 µm (b) 600 rpm 
having diameter 162.5 µm (c) 700 rpm having diameter 157.5 µm (d) 800 rpm having 
diameter 132.5 µm using 1% alginate and 30G syringe. 
 
5.3 Micro-alginate beads from 2% alginate solution with 26G syringe needle (O.D (450 
µm), I.D (250 µm)): 
There was no formation of beads at 800 rpm. 900 rpm was the least rpm at which beads 
formed. Diameter of beads was found to be 145 µm as shown in fig. 9(a). The formation of 
beads was checked for three other rpm, say 600, 700, 800 rpm and the diameter of 
microbeads was found as 140 µm as shown in fig. 9(b), 135 µm as shown in fig. 9(c), 130 µm 
as shown in fig. 9(d). From the graph it can be seen that as the rpm increased the bead 
diameter decreased.  
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(a)                                                               (b) 
 
 
                                     (c)                                                                 (d) 
Fig. 9: Micro-alginate beads formed at (a) 900 rpm having diameter 145 µm (b) 1000 
rpm having diameter 140 µm (c) 1100 rpm having diameter 135 µm (d) 1200 rpm 
having diameter 130 µm using 2% alginate and 26G syringe. 
 
5.4 Micro-alginate beads from 2% alginate solution with 30G syringe needle (O.D (300 
µm), I.D (148 µm)) 
There was no formation of beads at 1400 rpm. 1500 rpm was the least rpm at which beads 
formed. Diameter of beads was found to be 110 µm as shown in fig. 10(a). The formation of 
beads was checked for three other rpm, say 1600, 1700, 1800 rpm and the diameter of 
microbeads was found as 95 µm as shown in fig. 10(b), 90 µm as shown in fig. 10(c), 87.5 
µm as shown in fig. 10(d). From the graph it can be seen that as the rpm increased the bead 
diameter decreased.  
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(a)                                                                  (b) 
 
(c)                                                               (d) 
Fig. 10:Micro-alginate beads formed at (a) 1500 rpm having diameter 110µm (b) 1600 
rpm having diameter 95 µm (c) 1700 rpm having diameter 90 µm (d) 1800 rpm having 
diameter 87.5 µm using 2% alginate and 30G syringe. 
 
5.5 Micro-alginate beads from 3% alginate solution with 26G syringe needle (O.D (450 
µm), I.D (250 µm)): 
There was no formation of beads at 1000 rpm. 1100 rpm was the least rpm at which beads 
formed. Diameter of beads was found to be 145 µm as shown in fig. 11(a). The formation of 
beads was checked for three other rpm, say 1200, 1300, 1400 rpm and the diameter of 
microbeads was found as 135 µm as shown in fig. 11(b), 130 µm as shown in fig. 11(c), 
127.5 µm as shown in fig. 11(d). From the graph it can be seen that as the rpm increased the 
bead diameter decreased.  
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(a)                                                             (b) 
 
 
(c)                                                            (d) 
Fig. 11: Micro-alginate beads formed at (a) 1100 rpm having diameter 145µm (b) 1200 
rpm having diameter 135 µm (c) 1300 rpm having diameter 130 µm (d) 1400 rpm 
having diameter 127.5 µm using 3% alginate and 26G syringe. 
 
5.6 Micro-alginate beads from 3% alginate solution with 30G syringe needle (O.D (300 
µm), I.D (148 µm)) 
There was no formation of beads at 1500 rpm. 1600 rpm was the least rpm at which beads 
formed. Diameter of beads was found to be 85 µm as shown in fig. 12(a). The formation of 
beads was checked for three other rpm, say 1700, 1800, 1900 rpm and the diameter of 
microbeads was found as 80 µm as shown in fig. 12(b), 75 µm as shown in fig. 12(c), 65 µm 
as shown in fig. 12(d). From the graph it can be seen that as the rpm increased the bead 
diameter decreased. 
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(a)                                                               (b) 
 
 
(c)                                                                (d) 
Fig. 12: Micro-alginate beads formed at (a) 1600 rpm having diameter 85µm (b) 1700 
rpm having diameter 80 µm (c) 1800 rpm having diameter 75 µm (d) 1900 rpm having 
diameter 65 µm using 3% alginate and 30G syringe. 
 
5.7 Comparison of experimental bead diameter and theoretical bead diameter 
Theoretical bead diameter was calculated from the two equation, one for surface tension and 
the other for centrifugal force and then equating those two equation. The theoretical diameter 
of Ca-alginate bead are systematically located above the experimental bead diameter. The 
reduction in diameter can be explained due to gelation process and accompanying shrinkage. 
Here as rpm is increased bead size decreases. This is due to inverse relationship of bead 
diameter and rpm which we get after equating surface tension force and centrifugal force. 
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5.7.1 For 1% alginate solution 
\ 
                                 (a)                                                                          (b) 
Fig.13: Comparison of theoretical and experimental micro-alginate bead diameter for  
1% alginate solution  using (a) 26G needle(b) 30G needle. 
 
5.7.2 For 2% alginate solution 
\  
                                  (a)                                                                          (b) 
Fig.14: Comparison of theoretical and experimental micro-alginate bead diameter for  2 
% alginate solution  using (a) 26G needle(b) 30G needle. 
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5.7.3 For 3% alginate solution 
 
 
                                   (a)                                                                              (b) 
Fig.15 Comparison of theoretical and experimental micro-alginate bead diameter for 3 
% alginate solution  using (a) 26G needle (b) 30G needle. 
 
5.8 Variation of minimum rpm at which bead formed w.r.t its alginate concentration 
As alginate concentration in increased, minimum rpm to form bead increases since there is 
direct relationship between rpm and alginate concentration which is derived from force 
balancing equation by equating centrifugal force and surface tension force. 
 
                              (a)                                                                    (b) 
Fig. 16:Variation of minimum rpm at which beads formed with respect to its alginate 
concentration for (a) 26G needle and (b) 30G needle. 
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6. CONCLUSION 
 
This study added micro-bead fabrication capabilities to the recently introduced centrifugal 
multiphase microfluidic platform. By adjusting the spinning frequency and the nozzle 
geometry, the bead size produced can be as low as 65 µm. This size of the alginate 
microbeads is compatible with applications for therapeutic cell encapsulation. Compared to 
existing methods, this novel centrifugal scheme offers pulse-free und thus well reproducible 
droplet generation. The ability of the centrifugal encapsulation technology to even process 
highly viscous liquids within small diameter and thus high-resistance micro-nozzles under the 
impact of the centrifugally induced artificial gravity conditions has been shown for highly 
concentrated Na-alginate. Besides the capability to process high-viscous liquids, another 
advantage of the centrifugal microencapsulation technology is its conceptually simple and 
low-cost set-up. 
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